TAF7L Antibody - Azide and BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-04990
Key Product Details
Species Reactivity
Human, Mouse, Rat
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Format
Azide and BSA Free
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Recombinant fusion protein containing a sequence corresponding to amino acids 363-462 of human TAF7L (NP_079161.3). SEEYLERQLQAEFIESGQYRANEGTSSIVMEIQKQIEKKEKKLHKIQNKAQRQKDLIMKVENLTLKNHFQSVLEQLELQEKQKNEKLISLQEQLQRFLKK
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for TAF7L Antibody - Azide and BSA Free
Application
Recommended Usage
Western Blot
1:200-1:2000
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS with 50% glycerol, pH7.3.
Format
Azide and BSA Free
Preservative
0.01% Thimerosal
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C. Avoid freeze-thaw cycles.
Background: TAF7L
Alternate Names
50kDa, CT40FLJ23157, RNA polymerase II TBP-associated factor subunit Q, TAF2QRNA polymerase II, Q, TAF7-like RNA polymerase II, TATA box binding protein (TBP)-associated factor, TATA box binding protein (TBP)-associated factor, RNA polymerase II, Q, TATA box-binding protein-associated factor 50 kDa, transcription initiation factor TFIID subunit 7-like
Gene Symbol
TAF7L
Additional TAF7L Products
Product Documents for TAF7L Antibody - Azide and BSA Free
Product Specific Notices for TAF7L Antibody - Azide and BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
⚠ WARNING: This product can expose you to chemicals including Methotrexate, which is known to the State of California to cause reproductive toxicity with developmental effects. For more information, go to www.P65Warnings.ca.gov